"After Adcomm’s Vaccine Recommendation, Can Novavax Make a Covid Comeback?"

Novavax could make a comeback as the FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommends updating COVID-19 shots to cover the latest XBB Omicron subvariant, particularly subvariant XBB.1.5 which accounts for over 65% of all new COVID-19 cases in the US. The committee also recommended a monovalent shot specifically targeting Omicron and its subvariants. Novava..